Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Top7 or 10 Tips > The Top Ten Management Failures

Tags

  • should
  • performance
  • operate
  • performance management
  • companies involved

  • Links

  • Discover the Benefits of Eating Organically Produced Food
  • Retirement Myths
  • Manifest The Life You Want
  • Just Other Articles - The Top Ten Management Failures

    Over the past month I have been reflecting on the topic of organisational management. I am surprised by the number of organisations that survive perhaps through the benefit of their size or monopolistic position even though they exhibit some of the very worst ma
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    nagement traits I've experienced.

    Some corporations like Enron, HIH and WorldCom do fall by the wayside, whilst others continue on in mediocrity. Organisations that are shaken up by a leader with a true vision for the organisation inevitably experience a degree
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    of pain that could have been avoided had previous leaders not exhibited one of the following top ten management failures.

    Misdirected goals: Leaders sometimes espouse a mantra about what to do because it is fashionable without actually collecti
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ng and analysing data and then developing goals based on real information.

    Corporate history is littered with examples. The internet boom gave history thousands of companies that spent billions of dollars on internet plays without understanding how customers wo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ld react to online experiences and in what time frames.

    Cost cutting for cost cutting's sake is another favourite. Leaders have to be seen to be tough on costs, and so they are but at times at a cost to what drives their business profitability.

    Phoney
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    eadership: Leaders who continually say one thing and do another confuse their subordinates to the point of distraction. They rob organisations of morale and direction.

    They know the right words and tend to love using lots of them, but nothing ever seem
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    s to transpire that demonstrates the words as being anything other than hollow. They are not to be trusted and should be shown the way to the door by boards as soon as possible.

    Poor performance management: Leaders who preside over performance
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    anagement systems which degrade into rituals preside over an organisation which is destined for mediocrity. When performance management systems do not objectively differentiate poor performance from good performance, the majority of employees will perform only t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    level that does not require too much effort.

    Performance appraisals which are partisan, based on hearsay, or just plain uninformed are of no use to an organisation and should be stopped. It is better to have no performance management system than a severely fla
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    wed one.

    Silo mentality: Allowing management silos to develop and continue to operate is a sure way of reducing efficiency as separate teams chase separate goals competing for what should always be limited resources or chasing the same goal wit
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    duplicated resources.

    Lack of control: Organisations which delegate responsibility routinely to people or functions that do not have the appropriate competence or data from which to make decisions, and then compound it by not measuring the per
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ormance of the processes, are rightly bound for failure. This is not delegation. It is abdication.

    Too many goals: A Chinese proverb holds true in organisations: "If you chase two rabbits, both will escape." To achieve one significant goal is a
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    difficult task. It requires good strategy aligning people, processes and objective measurement of performance against the goal. Chasing two or three, or in many cases, four or more goals makes it too difficult to make the alignment and be objective about measur
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ment of performance against the goal.

    Excess of control: Leaders who insist on controlling everything at all times are at best likely to leave the organisation with an ineffective team unable to make decisions upon their departure. At worst the
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    will build a sycophantic team of "yes" men or women running an inefficient organisation

    No goals: Not having a goal or having a nebulous goal such as "World's best practice", at least makes it easy to claim to have achieved the goal. That is,
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    nothing or nothing that can be measured objectively.

    No performance management: Not measuring the performance of people, financial and physical assets and intellectual property is okay if your organisation finds it almost impossible not to make
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    money or deliver the services that your customers require within your budget.

    Inappropriate leadership style: A command and control style of leadership in an organisation which requires creativity is bound to fail. Equally, a laissez-faire lead
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    rship style in the military or police force would be equally disastrous. Leadership needs to be appropriate not only to the organisation, but also the circumstance.

    Organisations succeed at times despite these management failures, but they do not thrive. They a
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    re unable also to withstand the pressure of adversity when the environment in which they operate turns against them.

    These are common failures in big organisations that by their sheer size forget what they are there for and what their goals are.

    Strong leaders
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ip with a clear well-communicated goal and a performance management system that objectively measures actual performance and determines corrective action are a must. In today's competitive environment, for big and small organisations alike, survival depends on it


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/46184/justotherarticles-The-Top-Ten-Management-Failures.html">The Top Ten Management Failures</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/46184/justotherarticles-The-Top-Ten-Management-Failures.html]The Top Ten Management Failures[/url]

    Related Articles:

    Commodity Futures Trading System - Why the System Used Is Important When Choosing a Broker

    Interview Tactics - Stand Out From The Crowd

    How To Make Your Next Networking Event A Success

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com